These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9292183)

  • 1. Expression of P-glycoprotein 170 in nasal mucosa may be increased with topical steroids.
    Henriksson G; Norlander T; Zheng X; Stierna P; Westrin KM
    Am J Rhinol; 1997; 11(4):317-21. PubMed ID: 9292183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of expression of galectin-7 in human nasal polyps by budesonide.
    Delbrouck C; Souchay C; Kaltner H; André S; Gabius HJ; Vandenhoven G; Hassid S
    B-ENT; 2005; 1(3):137-44. PubMed ID: 16255498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topical glucocorticoid treatment on nasal mucosal mast cells in allergic rhinitis.
    Pipkorn U
    Allergy; 1983 Feb; 38(2):125-9. PubMed ID: 6846738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids decrease c-fos expression in human nasal polyps in vivo.
    Baraniuk JN; Wong G; Ali M; Sabol M; Troost T
    Thorax; 1998 Jul; 53(7):577-82. PubMed ID: 9797757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide.
    Knutsson PU; Brönnegård M; Marcus C; Stierna P
    J Allergy Clin Immunol; 1996 Feb; 97(2):655-61. PubMed ID: 8621851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of intercellular adhesion molecule-1 on the vascular endothelium in nasal polyps before, during and after topical glucocorticoid treatment.
    Tingsgaard PK; Larsen PL; Bock T; Lange Vejlsgaard G; Tos M
    Acta Otolaryngol; 1998 Jun; 118(3):404-8. PubMed ID: 9655217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps.
    Mullol J; Xaubet A; López E; Roca-Ferrer J; Picado C
    Thorax; 1995 Mar; 50(3):270-4. PubMed ID: 7660341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge.
    Hilberg O
    Allergy; 1995 Aug; 50(8):683-8. PubMed ID: 7503405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a topical glucocorticoid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique.
    Bende M; Lindqvist N; Pipkorn U
    Allergy; 1983 Oct; 38(7):461-4. PubMed ID: 6356965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of topical corticosteroids in the nose.
    Bende M; Mark J
    J Laryngol Otol; 1992 Sep; 106(9):810-2. PubMed ID: 1431520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide inhibits plasma extravasation induced by capsaicin and by substance P in the rat nasal mucosa.
    Bacci E; Bertrand C; Geppetti P; Baker J; Nadel JA; Laitinen LA; Petersson G
    Regul Pept; 1993 Dec; 49(2):159-66. PubMed ID: 7510897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways.
    Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG
    Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids.
    Kim YK; Uno M; Hamilos DL; Beck L; Bochner B; Schleimer R; Denburg JA
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):388-97. PubMed ID: 10030836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season.
    Klementsson H; Svensson C; Andersson M; Venge P; Pipkorn U; Persson CG
    Clin Exp Allergy; 1991 Nov; 21(6):705-10. PubMed ID: 1777832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids.
    Stoop AE; van der Heijden HA; Biewenga J; van der Baan S
    Eur Arch Otorhinolaryngol; 1992; 249(6):313-7. PubMed ID: 1358129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology and treatment of rhinitis medicamentosa.
    Graf P; Hallén H; Juto JE
    Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):224-9. PubMed ID: 7554332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis.
    Svensson C; Klementsson H; Andersson M; Pipkorn U; Alkner U; Persson CG
    Allergy; 1994 Mar; 49(3):177-83. PubMed ID: 8198250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids.
    Kim YK; Nakagawa N; Nakano K; Sulakvelidze I; Dolovich J; Denburg J
    J Allergy Clin Immunol; 1997 Sep; 100(3):389-99. PubMed ID: 9314353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps.
    Tingsgaard PK; Bock T; Larsen PL; Tos M
    Acta Otolaryngol; 1999; 119(3):362-8. PubMed ID: 10380744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal polyp inflammation. Effect of topical nasal steroid.
    Kanai N; Denburg J; Jordana M; Dolovich J
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1094-100. PubMed ID: 7921442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.